Publication: Anti-inflammatory effects of bromelain in lps-induced human U937 macrophages
Issued Date
2018-01-01
Resource Type
ISSN
01252526
Other identifier(s)
2-s2.0-85040930248
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Chiang Mai Journal of Science. Vol.45, No.1 (2018), 299-307
Suggested Citation
Thitima Kasemsuk, Pornpun Vivithanaporn, Supeenun Unchern Anti-inflammatory effects of bromelain in lps-induced human U937 macrophages. Chiang Mai Journal of Science. Vol.45, No.1 (2018), 299-307. Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/45300
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Anti-inflammatory effects of bromelain in lps-induced human U937 macrophages
Other Contributor(s)
Abstract
© 2018, Chiang Mai University. All rights reserved. Bromelain, a natural product from pineapple, is known for its anti-inflammatory and immunomodulatory activities. However, there was limited evidence to demonstrate bromelain effects on chemokines. Here, we aim to investigate the effects of bromelain on the expression of chemokines induced by lipopolysaccharide (LPS) on human U937 macrophages. Expression of chemokine, cytokine and cyclooxygenase-2 (COX-2) messenger RNAs (mRNAs) in LPS-stimulated macrophages in the absence or presence of bromelain was determined by real time polymerase chain reaction (PCR). Cytotoxicity was evaluated by 3-[4,5-dimethylthiazol- 2-yl]-2,5 diphenyl tetrazolium bromide (MTT) assays. Co-treatment of LPS and bromelain at 100 μg/mL exhibited inhibitory effects on the expression of the proinflammatory genes including macrophage inflammatory protein-1alpha (MIP-1α) (P < 0.05), macrophage inflammatory protein-1beta (MIP-1α) (P < 0.01), monocyte chemoattractant protein-1 (MCP- 1) (P < 0.01), interleukin-8 (IL-8) (P < 0.05), interleukin-1beta (IL-1β) (P < 0.05), interleukin- 6 (IL-6) (P < 0.01) and COX-2 (P < 0.05) when compared to LPS exposure. Bromelain showed anti-inflammation effects in macrophages by suppressing pro-inflammatory cytokines, chemokines and the cyclooxygenase pathway. Accordingly, these effects may be therapeutically useful for the treatment of inflammatory diseases.